Diana H. Liang, MD FACS
Department of Breast Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2012 | University of Texas Southwestern Medical School, Dallas, Texas, US, MD |
| 2008 | Rice University, Houston, Texas, US, Biological Sciences, BA |
Postgraduate Training
| 2019-2020 | Clinical Fellowship, Breast Surgical Oncology, MD Anderson Cancer Center, Houston, Texas |
| 2014-2016 | Research Fellowship, Houston Methodist Hospital, Houston, Texas |
| 2012-2019 | Clinical Residency, General Surgery, Houston Methodist Hospital, Houston, Texas |
Licenses & Certifications
| 2019 | American Board of Surgery |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020
Institutional Committee Activities
Member, Institutional Review Board, 2024 - Present
Breast Surgical Oncology Representative, Medical Records Committee, 2023 - Present
Breast Surgical Oncology Representative, NWSSC Safety Committee, 2023 - Present
Representative, BSO Fellowship Clinical Competency Review Committee, 2021 - 2022
Breast Surgical Oncology Representative, Patient Reported Outcomes Committee, 2021 - Present
Honors & Awards
| 2020 | Winner, Cancer Abstract Competition, American College of Surgeons Quality and Safety Conference |
| 2016 | Winner, Cancer Paper Competition, South Texas American College of Surgeons |
| 2015 | Recipient, AACR Scholar-in-Training Award, San Antonio Breast Cancer Symposium |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Indications for post-mastectomy radiation therapy. Conference. Houston, Texas, US.
- 2023. Indications for post-mastectomy radiation therapy. Conference. Houston, TX, US.
- 2022. Indications for post mastectomy radiation therapy. Conference. Houston, TX, US.
National Presentations
- 2020. Pilot study of circulating tumor cells before and after neoadjuvant chemotherapy in non-metastatic inflammatory breast cancer. Breast Virtual Forum. Conference. Society of Surgical Oncology Annual Meeting, US.
- 2020. Effective localization of non-palpable breast lesions using Magseed. Oral Presentation. Abstract Category Winners #1 Panel Session. Conference. American College of Surgeons. Virtual Quality and Safety Conference, US.
- 2015. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients. Poster. Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
Selected Publications
Peer-Reviewed Articles
- Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KK. Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol 29(6):3822-3828, 2022. e-Pub 2022. PMID: 35233742.
- Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KK. Correction to: Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol. e-Pub 2022. PMID: 35298763.
- Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome M. Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol 124(7):989-994, 2021. e-Pub 2021. PMID: 34328640.
- Elango R, Sheng Z, Jackson J, DeCata J, Ibrahim Y, Pham NT, Liang DH, Sakofsky CJ, Vindigni A, Lobachev KS, Ira G, Malkova A. Break-induced replication promotes formation of lethal joint molecules dissolved by Srs2. Nat Commun 8(1):1790, 2017. e-Pub 2017. PMID: 29176630.
- Liang DH, Choi DS, Ensor JE, Kaipparettu BA, Bass BL, Chang JC. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett 376(2):249-58, 2016. e-Pub 2016. PMID: 27060208.
- Tanei T, Choi DS, Rodriguez AA, Liang DH, Dobrolecki L, Ghosh M, Landis MD, Chang JC. Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells. Breast Cancer Res 18(1):6, 2016. e-Pub 2016. PMID: 26757880.
- Liang DH, Ensor JE, Liu ZB, Patel A, Patel TA, Chang JC, Rodriguez AA. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients. Breast Cancer Res Treat 155(1):139-49, 2016. e-Pub 2016. PMID: 26667234.
- Liang DH, El-Zein R, Dave B. Autophagy Inhibition to Increase Radiosensitization in Breast Cancer. J Nucl Med Radiat Ther 6(5), 2015. e-Pub 2015. PMID: 26613064.
Book Chapters
- Carlson KA, Liang D, Fayanju OM, Garvey PB, Karuturi MS, Bedrosian I, Hunt KK. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast. In: Bland and Copeland's The Breast. 6. Elsevier Inc, 627-640, 2024.
- Liang DH, Hall C, Lucci A. Circulating Tumor Cells in Breast Cancer. In: Recent Results Cancer Res, 127-145, 2020.
Patient Reviews
CV information above last modified July 07, 2025